Defective ATM-p53-mediated apoptotic pathway in multiple sclerosis.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 16178012.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Defective elimination of autoreactive cells is thought to play a role in the development of autoimmune diseases including multiple sclerosis (MS). We examined the activation of the ATM-CHK2-p53 pathway in MS patients after subjecting their peripheral blood mononuclear cells to gamma-irradiation. We found that peripheral blood mononuclear cells from a subset of MS patients show resistance to cell death induced by irradiation. This defect is due to impaired constitutive expression and activation of ATM (ataxia telangiectasia mutated), resulting in impaired stabilization of p53. We predict that these fundamental defects likely alter the regulation of the immune population of cells in MS and may contribute to the development or progression of the disease.
Medical subject headings
- Apoptosis
- DNA-Binding Proteins
- Gene Expression Regulation
- Multiple Sclerosis
- Protein Serine-Threonine Kinases
- Tumor Suppressor Protein p53
- Tumor Suppressor Proteins